NuCana's R&D On Agents For Drug-Resistant Cancers Gets IPO Boost

 
• By John Davis
  
Edinburgh
Edinburgh, where NuCana is based. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business